Page last updated: 2024-10-15

corallopyronin a

Description

corallopyronin A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163060205
MeSH IDM0526674

Synonyms (1)

Synonym
corallopyronin a

Research Excerpts

Overview

Corallopyronin A is a myxobacterial compound with potent antibacterial activity. It is an antibiotic to develop further for filariasis elimination without concern for cross-resistance in tuberculosis.

ExcerptReference
"Corallopyronin A is a potent antimicrobial that exhibits activity against Chlamydia spp."( Potent
Alt, S; Ayala, JC; Balthazar, JT; Edwards, JL; Esposito, DLA; Golparian, D; Grosse, M; Hesterkamp, T; Hoerauf, A; Pfarr, K; Read, TD; Schiefer, A; Shafer, WM; Stadler, M; Unemo, M, 2022
)
"Corallopyronin A is a promising in vivo active antibiotic, currently undergoing preclinical evaluation. "( Function of the loading module in CorI and of the O-methyltransferase CorH in vinyl carbamate biosynthesis of the antibiotic corallopyronin A.
König, GM; Lohr, F; Mir Mohseni, M; Schäberle, TF; Schmitz, A, 2014
)
"Corallopyronin A is a myxobacterial compound with potent antibacterial activity. "( Biosynthesis of the myxobacterial antibiotic corallopyronin A.
El Omari, M; Erol, O; Gurgui, C; Kehraus, S; König, GM; Lohr, F; Müller, R; Piel, J; Rachid, S; Schäberle, TF; Schmitz, A, 2010
)
"Corallopyronin A is an antibiotic to develop further for filariasis elimination without concern for cross-resistance development in tuberculosis."( Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo.
Hoerauf, A; Johnston, KL; König, GM; Lämmer, C; Pfarr, K; Schäberle, TF; Schiefer, A; Schmitz, A; Specht, S; Vassylyev, DG, 2012
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.26)29.6817
2010's15 (78.95)24.3611
2020's3 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (15.79%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (84.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]